东方生物 (688298.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(东方生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) -1.00---6.002.004.0017.00
 单季度销售毛利率(%) 43.0044.0033.0010.0038.0045.0064.00
 单季度销售净利率(%) -70.0067.00-12.00-109.0042.0029.0044.00
 单季度净资产收益率ROE(%) -1.001.00-1.00-11.003.008.0026.00
 单季度总资产净利率ROA(%) -1.001.00--9.003.006.0020.00
单季度财务摘要:
 单季度营业总收入(元) 150,627,973.00125,498,602.00376,045,281.00910,179,304.00746,518,004.002,365,015,005.004,746,225,793.00
 单季度营业总成本(元) 261,153,177.0033,292,025.00424,274,589.001,044,493,046.00395,571,328.001,414,174,573.002,213,803,834.00
 单季度营业收入(元) 150,627,973.00125,498,602.00376,045,281.00910,179,304.00746,518,004.002,365,015,005.004,746,225,793.00
 单季度营业利润(元) -105,169,081.0062,176,915.00-1,445,689.00-1,167,066,838.00401,847,975.00782,768,224.002,510,660,740.00
 单季度利润总额(元) -105,456,671.0096,871,688.00-37,655,036.00-1,182,543,405.00383,717,628.00777,495,574.002,492,082,567.00
 单季度净利润(元) -105,212,688.0084,359,206.00-46,412,877.00-988,929,044.00309,867,099.00677,827,771.002,098,665,411.00
 单季度归属母公司股东的净利润(元) -107,191,567.0085,137,662.00-50,330,075.00-983,820,073.00309,888,879.00674,965,764.002,066,679,758.00
 单季度经营活动产生的现金流量(元) -432,631,184.00-455,480,053.00-731,563,867.001,097,594,075.00-434,813,327.00559,021,747.001,774,121,997.00
 单季度投资活动产生的现金流量(元) -68,350,919.00-96,640,985.00-56,819,149.00-1,680,332,811.00-164,333,059.00-16,496,726.00-514,537,538.00
 单季度筹资活动产生的现金流量(元) -50,316,254.00-412,577,171.00498,216,181.0086,774,725.007,188,317.00--
 单季度现金及现金等价物净增加(元) -588,546,353.00-795,695,533.00-327,378,567.00-525,923,072.00-47,143,555.00-203,687,531.001,235,375,930.00

前瞻产业研究院